Total : 54 View more »
Nation's Largest Nursing Home Pharmacy and Drug Manufacturer to Pay $112 Million to Settle False Claims Act Cases.
COVINGTON, Ky.--(BUSINESS WIRE)--The Board of Directors of Omnicare, Inc. (NYSE:OCR - News), a leading provider of pharmaceutical care for
http://finance.yahoo.com/news/Omnicare-Declares-Quarterly-bw-1302412002.html?x=0
CBS Evening News (11/3, story 9, 1:40, Smith) reported, "As members of Congress debate healthcare reform, most would agree there needs to be a crackdown on cheating. Chief Investigative Correspondent Armen Keteyian reports now on a staggering fraud settlement involving...
http://www.injury-and-disability.com/2009/11/omnicare-will-settle-kickback-cases-for-98000000.html
Class Action Alleging Securities Fraud Properly Dismissed because Class Action Complaint Failed to Meet Heightened Pleading Requirements Established by Private Securities Litigation Reform Act (PSLRA) Sixth Circuit Holds Plaintiffs filed a putative class action against Omnicare and
http://classactiondefense.jmbm.com/2009/11/pslra_class_action_defense_cas_24.html
Total : 37 View more »
COVINGTON, Ky., Nov 20, 2009 (BUSINESS WIRE) --
The Board of Directors of Omnicare, Inc. (NYSE:OCR), a leading provider of pharmaceutical care for the elderly, declared today a quarterly cash dividend of 2.25 cents ($0.0225) per share on its common stock. The dividend is payable December 21, 2009 to stockholders of record on December 7, 2009.
Omnicare, Inc. (NYSE:OCR), a Fortune 500 company based in Covington, Kentucky, is a leading provider of pharmaceutical care for the elderly. Omnicare serves residents in long-term care facilities, chronic care and other settings comprising approximately 1.4 million beds in 47 states, the District of Columbia and Canada. Omnicare is the largest U.S. provider of professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings. Omnicare's pharmacy services also include distribution and patient assistance services for specialty pharmaceuticals. Omnicare offers clinical research services for the pharmaceutical and biotechnology industries in 31 countries worldwide.
For more information on Omnicare, visit www.omnicare.com.
SOURCE: Omnicare, Inc.
Omnicare, Inc. Cheryl D. Hodges, 859-392-3331
Tags: biotechnology canada clinical consulting dividend healthcare kentucky nyse pharmaceuticals pharmacy research
Companies: Omnicare, Inc. (OCR)
COVINGTON, Ky., Nov 13, 2009 (BUSINESS WIRE) --
Omnicare, Inc. (NYSE:OCR), a leading provider of pharmaceutical care for the elderly, announced today that it will participate in the Sixth Annual Lazard Capital Markets Healthcare Conference on November 17 at 1:40 p.m. EST in New York, New York. Presenting for Omnicare will be David W. Froesel, Jr., senior vice president and chief financial officer.
The presentation will be broadcast live over the Internet and can be accessed at http://www.wsw.com/webcast/lz6/ocr/. Please allow extra time prior to the presentation to visit the site and download the streaming media software required to listen to the Internet broadcast. Following the conference, an archived version of the webcast will be available for 14 days.
About Omnicare, Inc.
Omnicare, Inc. (NYSE:OCR), a Fortune 500 company based in Covington, Kentucky, is a leading provider of pharmaceutical care for the elderly. Omnicare serves residents in long-term care facilities, chronic care and other settings comprising approximately 1.4 million beds in 47 states, the District of Columbia and Canada. Omnicare is the largest U.S. provider of professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings. Omnicare's pharmacy services also include distribution and patient assistance services for specialty pharmaceuticals. Omnicare offers clinical research services for the pharmaceutical and biotechnology industries in 31 countries worldwide. For more information, visit the company's Web site at www.omnicare.com.
SOURCE: Omnicare, Inc.
Omnicare, Inc. Cheryl D. Hodges, 859-392-3331
Tags: biotechnology canada clinical conference consulting healthcare kentucky media new_york nyse pharmaceuticals pharmacy president research software web
Companies: Omnicare, Inc. (OCR)
Nov 06, 2009 (Close-Up Media via COMTEX) --
Omnicare, Inc. has announced that it has finalized a previously disclosed agreement in principle for a voluntary civil settlement with the U.S. Attorney's Office, District of Massachusetts, the Departments of Justice and Health and Human Services, as well as various of the states in which the Company does business.
In a release, the Company noted that the settlement relates to the previously disclosed investigation with respect to qui tam complaints filed against the Company. The Company said that it cooperated fully with the review of these matters and is pleased to have reached a resolution.
Omnicare said that the Settlement Agreement does not include any finding of wrongdoing or any admission of liability by Omnicare. The Company denies the contentions of the federal government and the qui tam relators as set forth in the complaints and further denies any liability related to those contentions. The allegations include claims that the Company purportedly purchased a medical supply business at an above-market price to induce the referral of business; allegedly received improper payments from pharmaceutical manufacturers; and purportedly provided consultant pharmacist services to customers at below cost and fair market value to induce the referral of business. The Company agreed to settle the matters in order to avoid expensive and time-consuming litigation and to focus on its mission of providing high-quality pharmaceutical care for the frail elderly.
Under the terms of the Settlement Agreement, Omnicare has agreed to pay $98 million plus interest (from June 24, the date of the aforementioned agreement in principle) to the federal government and the participating states and the District of Columbia and related expenses. Consistent with previous disclosure, this amount has been reserved by Omnicare. Omnicare has also voluntarily entered into an Amended and Restated Corporate Integrity Agreement (CIA) with the Department of Health and Human Services. The CIA will be in effect for a period of five years and provides for, among other things, training and oversight to demonstrate Omnicare's commitment to comply with the applicable laws and regulations governing pharmacies.
Omnicare, Inc. is a provider of pharmaceutical care for the elderly.
((Comments on this story may be sent to health@closeupmedia.com))
Tags: business consultant corporate elderly government health investigation market massachusetts medical pharmaceuticals regulations training
Companies: Omnicare, Inc. (OCR)
COVINGTON, Ky., Nov 06, 2009 (BUSINESS WIRE) --
Omnicare, Inc. (NYSE:OCR), a leading provider of pharmaceutical care for the elderly, announced today that it will participate in the Credit Suisse 18th Annual Healthcare Conference on November 11 at 1:00 p.m. EST in Phoenix, Arizona. Presenting for Omnicare will be Joel F. Gemunder, president and chief executive officer.
The presentation will be broadcast live over the Internet and can be accessed at http://w.on24.com/r.htm?e=174681&s=1&k=AC156CE46FBC1EE04485532C9E1E134F. Please allow extra time prior to the presentation to visit the site and download the streaming media software required to listen to the Internet broadcast. Following the conference, an archived version of the webcast will be available for 14 days.
About Omnicare, Inc.
Omnicare, Inc. (NYSE:OCR), a Fortune 500 company based in Covington, Kentucky, is a leading provider of pharmaceutical care for the elderly. Omnicare serves residents in long-term care facilities, chronic care and other settings comprising approximately 1.4 million beds in 47 states, the District of Columbia and Canada. Omnicare is the largest U.S. provider of professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings. Omnicare's pharmacy services also include distribution and patient assistance services for specialty pharmaceuticals. Omnicare offers clinical research services for the pharmaceutical and biotechnology industries in 31 countries worldwide. For more information, visit the company's Web site at www.omnicare.com.
SOURCE: Omnicare, Inc.
Omnicare, Inc. Cheryl D. Hodges, 859-392-3331
Tags: biotechnology canada ceo clinical conference consulting healthcare kentucky media nyse pharmaceuticals pharmacy president research software web
Companies: Omnicare, Inc. (OCR)
Total : 91 View more »
Health, ... Omnicare Inc. which calls itself "the nation's leading provi...Wilmington DE (PRWEB) May 22 2009 -- Omnicare Inc. which calls
Home Pharmacy Clinical Research Technology Services MMA News Investors Employment Our business is pharmaceutical care. Our mission is positive outcomes. [image] [image] [image] [image] Omnicare The nation's leading provider of pharmaceutical care for seniors. Omnicare, Inc. • 1600 RiverCenter II,
Nolan & Auerbach, P.A. is a qui tam law firm whose practice is uniquely limited to healthcare fraud cases under the qui tam provisions of the False Claims Act. We know healthcare fraud because that's what we do! Toll free: 800-FRAUD 04 http://www.pharmaceutical-kickbacks.com/26/
"We have maintained throughout this litigation that UnitedHealth Group's dealings with Omnicare and its acquisition of PacifiCare were conducted in good faith and we are gratified that the Court agrees," said Peter H. Walsh, senior deputy general counsel of UnitedHealth Group.
Total : 534 View more »
Omnicare Incorporated. The Group's principal activities are to provide pharmaceuticals and related pharmacy services to long-term care institutions. It operates in two segments ...
http://www.corporateinformation.com/Company-Snapshot.aspx?cusip=681904108
Omnicare is the nation's leading provider of pharmaceutical care for seniors. Each day, our pharmacists serve more than 1.4 million residents of skilled nursing, assisted living ...
Omnicare Incorporated. The Group's principal activities are to provide pharmaceuticals and related pharmacy services to long-term care institutions. It operates in two segments ...
http://wrightreports.ecnext.com/coms2/reportdesc_COMPANY_681904108
Get the latest OCR - Omnicare Incorporated stock market performance data. TheStreet is the source for financial market news, trading stock, quotes, and personal finance advice.